Stass S - Search Results

1

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.

Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Ginsberg C, Stass S, Kantarjian H, Keating MJ. Robertson LE, et al. Among authors: stass s. Blood. 1992 Jul 1;80(1):29-36. Blood. 1992. PMID: 1377051 Free article.

2

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.

Claxton D, Deisseroth A, Talpaz M, Reading C, Kantarjian H, Trujillo J, Stass S, Gooch G, Spitzer G. Claxton D, et al. Among authors: stass s. Blood. 1992 Feb 15;79(4):997-1002. Blood. 1992. PMID: 1371081 Free article.

3

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia.

Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R. Kantarjian HM, et al. Among authors: stass s. Blood. 1991 Nov 1;78(9):2411-8. Blood. 1991. PMID: 1932753 Free article.

4

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy.

Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S. Kantarjian HM, et al. Among authors: stass s. Blood. 1990 Aug 15;76(4):808-13. Blood. 1990. PMID: 2166608 Free article.

5

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders.

O'Brien S, Kurzrock R, Duvic M, Kantarjian H, Stass S, Robertson LE, Estey E, Pierce S, Keating MJ. O'Brien S, et al. Among authors: stass s. Blood. 1994 Aug 1;84(3):733-8. Blood. 1994. PMID: 7913841 Free article. Clinical Trial.

6

All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia.

Cortes JE, Kantarjian H, O'Brien S, Robertson LE, Koller C, Hirsh-Ginsberg C, Stass S, Keating M, Estey E. Cortes JE, et al. Among authors: stass s. Cancer. 1994 Jun 15;73(12):2946-52. doi: 10.1002/1097-0142(19940615)73:12<2946::aid-cncr2820731211>3.0.co;2-q. Cancer. 1994. PMID: 8199992 Clinical Trial.

7

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy.

Lee MS, Kantarjian H, Talpaz M, Freireich EJ, Deisseroth A, Trujillo JM, Stass SA. Lee MS, et al. Among authors: stass sa. Blood. 1992 Apr 15;79(8):1920-3. Blood. 1992. PMID: 1562719 Free article.

8

RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.

Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Freireich EJ, Trujillo JM, Lee MS, Stass SA. Hirsch-Ginsberg C, et al. Among authors: stass sa. Blood. 1990 Sep 15;76(6):1214-9. Blood. 1990. PMID: 2205309 Free article.

9

Molecular heterogeneity in acute leukemia lineage switch.

Gagnon GA, Childs CC, LeMaistre A, Keating M, Cork A, Trujillo JM, Nellis K, Freireich E, Stass SA. Gagnon GA, et al. Among authors: stass sa. Blood. 1989 Nov 1;74(6):2088-95. Blood. 1989. PMID: 2553159 Free article.

10

Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.

LeMaistre A, Lee MS, Talpaz M, Kantarjian HM, Freireich EJ, Deisseroth AB, Trujillo JM, Stass SA. LeMaistre A, et al. Among authors: stass sa. Blood. 1989 Mar;73(4):889-91. Blood. 1989. PMID: 2645949 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters